HER2 alterations and prognostic implications in all subtypes of breast cancer. ASCO, Abst:1041, 6/2022

K O'Keefe; Dave S.B. Hoon; See all authors in notes

HER2 alterations and prognostic implications in all subtypes of breast cancer. ASCO, Abst:1041, 6/2022

K O'Keefe, Dave S.B. Hoon, See all authors in notes

Research output: Contribution to conference › Abstract

Original language	American English
State	Published - 2022

Cite this

@conference{5bedbfa62be84aac80e93f7c5f72bc37,

title = "HER2 alterations and prognostic implications in all subtypes of breast cancer. ASCO, Abst:1041, 6/2022",

author = "K O'Keefe and Hoon, {Dave S.B.} and {See all authors in notes}",

note = "289. O{\textquoteright}Keefe K, Elliott A, Livasy C, Steiner M, Kang I, Hoon DSB, Korn WM, Walker P, Radovich M, Pohlmann PR, Swain SM, Tan AR, Heeke AL",

year = "2022",

language = "American English",

}

TY - CONF

T1 - HER2 alterations and prognostic implications in all subtypes of breast cancer. ASCO, Abst:1041, 6/2022

AU - O'Keefe, K

AU - Hoon, Dave S.B.

AU - See all authors in notes,

N1 - 289. O’Keefe K, Elliott A, Livasy C, Steiner M, Kang I, Hoon DSB, Korn WM, Walker P, Radovich M, Pohlmann PR, Swain SM, Tan AR, Heeke AL

PY - 2022

Y1 - 2022

M3 - Abstract

ER -